Pharmacological evaluation of IQM-95,333, a highly selective CCK(A) receptor antagonist with anxiolytic-like activity in animal models

Article

Abstract: 1. The pyridopyrimidine derivative IQM-95,333 ((4aS,5R)-2-benzyl-5-[N(α)-tert-butoxicarbonyl)L-trypt

Palabras claves:

Amylase release, Anxiolytic drugs, CCK(A) receptors, CCK(B) receptors, Cholecystokinin (CCK), Food intake

Autores:

Barber A., Del Río J., Fortuno A., Garcı́a-López M.T., Gómez-Monterrey I., Gonzalez-Muniz R., Herranz R., Martín-Martínez M., Santiago J. Ballaz

Fuentes:

scopus